BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20828419)

  • 21. Double Bence Jones proteinuria.
    Kanoh T; Yago K
    Arch Pathol Lab Med; 1990 Sep; 114(9):991-4. PubMed ID: 2117911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Leukemia of plasma cells].
    Martínez-Cairo S; Gutiérrez Lizardi P; Ramos Torres J
    Prensa Med Mex; 1976; 41(11-12):400-3. PubMed ID: 1026934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgE myeloma: total body tumor cell number and synthesis of IgE and DNA.
    Salmon SE; McIntyre OR; Ogawa M
    Blood; 1971 Jun; 37(6):696-705. PubMed ID: 5170691
    [No Abstract]   [Full Text] [Related]  

  • 24. The expanding spectrum of clinical and laboratory features of IgE myeloma. (Report of a case and review of the literature).
    Dammacco F; Miglietta A; Tribalto M; Mandelli F; Bonomo L
    Ric Clin Lab; 1980; 10(4):583-90. PubMed ID: 7209293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgE plasma cell leukemia successfully treated with combination VAD (vincristine, doxorubicin, dexamethasone) and MP (melphalan, prednisolone) followed by interferon-alpha.
    Yamagata N; Shimazaki C; Goto H; Hirata T; Ashihara E; Oku N; Inaba T; Fujita N; Nakagawa M
    Am J Hematol; 1994 Mar; 45(3):262-4. PubMed ID: 8296801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient with double bence jones proteinuria after hematopoietic cell transplantation.
    Méndez-Arredondo JA; Rodríguez-López I; González-Morales I; Debén-Ariznavarreta G; Fernández-Rodríguez F; Sánchez-Mozo P
    Arch Pathol Lab Med; 2005 Jul; 129(7):937-9. PubMed ID: 15974821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unusual myelomas: a review of IgD and IgE variants.
    Pandey S; Kyle RA
    Oncology (Williston Park); 2013 Aug; 27(8):798-803. PubMed ID: 24133829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.
    Dogaru M; Lazăr V; Coriu D
    Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma.
    Hayes MJ; Carey JL; Krauss JC; Hedstrom DL; Gulbranson RL; Keren DF
    Eur J Haematol; 2007 Apr; 78(4):353-7. PubMed ID: 17378894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [IgE myeloma. Laboratory typing difficulties].
    Bovone NS; Fuente MC; Gastiazoro AM; Alfonso G; Freitas MJ
    Medicina (B Aires); 2014; 74(6):472-3. PubMed ID: 25555008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-secretory or low-secretory myeloma with intracellular kappa chains. Report of six cases and review of the literature.
    Turesson I; Grubb A
    Acta Med Scand; 1978; 204(6):445-51. PubMed ID: 104550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressive effect of IgE soluble immune complex on neutrophil chemotaxis.
    Ito S; Shinomiya K; Mikawa H
    Clin Exp Immunol; 1983 Feb; 51(2):407-12. PubMed ID: 6404574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple myeloma terminating as plasma cell leukemia and coinciding with a change in light chain production.
    Grammens GL; Ellis RW
    Minn Med; 1980 Mar; 63(3):179-80, 209. PubMed ID: 6768977
    [No Abstract]   [Full Text] [Related]  

  • 34. Secondary monoclonal gammopathy of undetermined significance is frequently associated with high response rate and superior survival in patients with plasma cell dyscrasias.
    Zou D; An G; Zhu G; Wang J; Shi L; Meng H; Xu Y; Sui W; Deng S; Zhan F; Qiu L
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):319-25. PubMed ID: 24296491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical spectrum of light chain myeloma. A study of 35 patients with special reference to the occurrence of amyloidosis.
    Stone MJ; Frendel EP
    Am J Med; 1975 May; 58(5):601-19. PubMed ID: 1130419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperviscosity syndrome in a patient with plasma cell leukemia.
    Douer D; Weinbergerr A; Djaldetti M; Asherov J; Pick I; Pinkhas J
    Acta Haematol; 1979; 62(2):81-5. PubMed ID: 119405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple myeloma with serum IgM kappa and Bence Jones lambda biclonal gammopathy.
    Graziani MS; Lippi U
    Clin Chem; 1986 Dec; 32(12):2220-1. PubMed ID: 3096615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgD myeloma. Report of a case with unusual clinical and immunologic features.
    Valenzuela R; Govindarajan S; Tubbs R; Deodhar S; Bukowski R
    Am J Clin Pathol; 1979 Aug; 72(2):246-50. PubMed ID: 112852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new case of IgE myeloma.
    Invernizzi F; Monti G; Caviglia AG; Meroni P; Zanussi C
    Acta Haematol; 1991; 85(1):41-4. PubMed ID: 2011930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgE myeloma. Report of a new case and review of the literature.
    Sala P; Tonutti E; Ruscio M; Colle R; Antonutto G; Falconieri G
    Haematologica; 1981 Dec; 66(6):787-95. PubMed ID: 6802719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.